Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0324
+0.0022 (7.32%)
At close: Aug 1, 2025
Brightcove Market Cap
Petros Pharmaceuticals has a market cap or net worth of $1.37 million as of August 1, 2025. Its market cap has decreased by -53.59% in one year.
Market Cap
1.37M
Enterprise Value
-7.56M
Revenue
5.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from 38.73M to 1.37M, a decrease of -96.46%. That is a compound annual growth rate of -51.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.37M | -65.20% |
| Dec 31, 2024 | 3.94M | 27.11% |
| Dec 29, 2023 | 3.10M | -35.68% |
| Dec 30, 2022 | 4.82M | -92.98% |
| Dec 31, 2021 | 68.71M | 60.87% |
| Dec 31, 2020 | 42.71M | 10.27% |
| Dec 2, 2020 | 38.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |